The presence of TAMs and high levels of specific chemokines and cytokines, including interleukin-6 (IL-6), is associated with lower survival rates in patients with several types of tumors, including neuroblastoma (NBL) for which the prognosis is poor in children with high-risk disease [3, 5–11]. The gene discussed is IL6; the disease is neuroblastoma.